SPP1 and postmenopausal osteoporosis: Clinical studies have shown that OPN is involved in bone strength and remodeling, suggesting that serum OPN is positively correlated with the severity of OP and could be targeted as a biomarker for early diagnosis of postmenopausal osteoporosis (31, 32).